Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of GILEAD SCIENCES BELGIUM is 0.6% (low). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
23 mandates
8
active directors
J.Peche Marín-LázaroDirectorJosephine Yang ComiskeyDirectorSabine TewsDirector+20 in history
All directors & mandates Publicationslatest 31-12-2025
66
publications in the State Gazette4 directors appointed, 1 resigningAll publications & acts Network & structure
1
connected companySee network & structure
Connections
1 connected companyParent · 926 subsidiaries · 5 locations
Control→
Trust signals
3 signalsEstablished
Founded in 2006 — 19 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.6%
Low
0%0,5%1,5%4%10%≥25%
Long track record
−Higher-failure-rate sector
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
| Legal nameNL | GILEAD SCIENCES BELGIUM |
Registered office
Culliganlaan 2D
1831 Machelen (Brab.), Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.